01/29/21 Reuters: J&J vaccine adds to COVID-19 armoury with 66% global trial efficacy
https://www.reuters.com/article/us-health-coronavirus-vaccines-johnson-j/jj-vaccine-adds-to-covid-19-armoury-with-66-global-trial-efficacy-idUSKBN29Y1PE
#JohnsonAndJohnson #Vaccine #Coronavirus #Outbreak #Pandemic #Covid19